Drug · DIN 02217422
MEPRON
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 25, 2002; first marketed September 10, 1996.
- Drug Identification Number (DIN)
- 02217422
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Atovaquone P01AX06
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ATOVAQUONE | 750 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 7, 2001: NOC 881New Drug Submission (NDS) · Change in manufacturer name
- April 4, 1996: NOC 4219Supplement to a New Drug Submission (SNDS) · New dosage form: oral suspension